Pfizer COVID-19 pill could cut severe illness by 89%, company says
Pfizer Inc. announced Friday that its pill to treat novel COVID-19 was found to reduce the risk of hospitalization or death by 89% among high-risk adult patients in a clinical trial.
Health
